Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 1/2020

01-03-2020 | Atopic Dermatitis | Infectious Disease and Dermatology (C Beard and K. Krishnamurthy, SECTION EDITORS)

Molluscum Contagiosum: Review and Update on Clinical Presentation, Diagnosis, Risk, Prevention, and Treatment

Authors: Gabrielle Robinson, Steven Townsend, Marla N. Jahnke

Published in: Current Dermatology Reports | Issue 1/2020

Login to get access

Abstract

Purpose of Review

Molluscum contagiosum (MC) is a self-limited cutaneous viral infection that most commonly affects children and immunocompromised populations. This review provides an update on the clinical manifestations, risk, diagnosis, treatment, and prevention of this frequently encountered infection.

Recent Findings

A recent Cochrane review concluded that there is insufficient evidence to establish the superiority of any specific treatment modality or to confirm that active intervention is superior to benign neglect (van der Wouden JC et al., Cochrane Database Syst Rev 5:CD004767, 2017). Interim pilot study data suggests that cantharidin outperforms placebo (Guzman AK et al., Int J Dermatol 57:1001–1006, 2018). Imiquimod is no longer recommended for treatment of MC (van der Wouden JC et al., Cochrane Database Syst Rev 5:CD004767, 2017; Papadopoulos EJ, https://www.fda.gov/files/drugs/published/N20-723S020-Imiquimod-Clinical-BPCA.pdf, 2006; Katz KA et al., Pediatr Dermatol 35:282–283, 2018).

Summary

Optimal management strategies for MC remain unclear due to the multitude of proposed therapies, lack of high-quality evidence, and uncertain benefit of intervention for uncomplicated disease. Aside from watchful waiting, destructive therapies such as cantharidin and curettage are among the best studied methods and remain the treatment of choice for most patients.
Literature
1.
Osio A, Deslandes E, Saada V, Morel P, Guibal F. Clinical characteristics of molluscum contagiosum in children in a private dermatology practice in the greater Paris area, France: a prospective study in 661 patients. Dermatology. 2011;222:314–20.CrossRefPubMed
2.
Braue A, Ross G, Varigos G, Kelly H. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol. 2005;22:287–94.CrossRefPubMed
3.
Dohil MA, Lin P, Lee J, Lucky AW, Paller AS, Eichenfield LF. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54:47–54. Accessed 06 Oct 2019.
4.
Hayashida S, Furusho N, Uchi H, Miyazaki S, Eiraku K, Gondo C, et al. Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis? J Dermatol Sci. 2010;60:173–8.
5.
Laxmisha C, Thappa DM, Jaisankar TJ. Clinical profile of molluscum contagiosum in children versus adults. Dermatol Online J. 2003;9:1.PubMed
6.
Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014;31: 130–136.
7.
Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis. 2013;13:877–88.CrossRefPubMed
8.
Fernando I, Pritchard J, Edwards SK, Grover D. UK national guideline for the management of Genital Molluscum in adults, 2014 Clinical Effectiveness Group, British Association for Sexual Health and HIV. Int J STD AIDS. 2015;26:687–95.CrossRefPubMed
9.
Czelusta A, Yen-Moore A, Van der Straten M, Carrasco D, Tyring SK. An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol. 2000;43:409–32 quiz 433–6.CrossRefPubMed
10.
Brown J, Janniger CK, Schwartz RA, Silverberg NB. Childhood molluscum contagiosum. Int J Dermatol. 2006;45:93–9.CrossRefPubMed
11.
Berger EM, Orlow SJ, Patel RR, Schaffer JV. Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes. Arch Dermatol. 2012;148:1257–64.CrossRefPubMed
12.
Zawar V, Goyal T, Doda D. Woronoff ring: a novel manifestation of molluscum contagiosum. Skinmed. 2016;14:349–52.PubMed
13.
Bakke JR, Stein SL. Molluscum contagiosum of the gluteal cleft: observations and implications for management in five children. Pediatr Dermatol. 2017;34:e191–5.CrossRefPubMed
14.
Berbegal-DeGracia L, Betlloch-Mas I, DeLeon-Marrero F-J, Martinez-Miravete MT, Miralles-Botella J. Neonatal molluscum contagiosum: five new cases and a literature review. Australas J Dermatol. 2015;56:e35–8.CrossRefPubMed
15.
Trčko K, Hošnjak L, Kušar B, Zorec TM, Kocjan BJ, Križmarić M, et al. Clinical, histopathological, and virological evaluation of 203 patients with a clinical diagnosis of molluscum contagiosum. Open Forum Infect Dis. 2018;5:ofy298.
16.
Basu S, Kumar A. Giant molluscum contagiosum—a clue to the diagnosis of human immunodeficiency virus infection. J Epidemiol Glob Health. 2013;3:289–91.CrossRefPubMedPubMedCentral
17.
• van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5:CD004767. This Cochrane review of randomized controlled trials investigating treatment of MC in immunocompetent patients found (a) moderate to high-quality evidence that 5% imiquimod is no more effective than its vehicle and (b) that there is insufficient data to provide evidence-based recommendations regarding the best treatment for MC.PubMed
18.
Choong KY, Roberts LJ. Molluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol. 1999;40:89–92.CrossRefPubMed
19.
Sturt RJ, Muller HK, Francis GD. Molluscum contagiosum in villages of the West Sepik District of New Guinea. Med J Aust. 1971;2:751–4.CrossRefPubMed
20.
21.
Mahé A, Prual A, Konaté M, Bobin P. Skin diseases of children in Mali: a public health problem. Trans R Soc Trop Med Hyg. 1995;89:467–70.CrossRefPubMed
22.
Niizeki K, Kano O, Kondo Y. An epidemic study of molluscum contagiosum. Relationship to swimming. Dermatologica. 1984;169:197–8.CrossRefPubMed
23.
Castilla MT, Sanzo JM, Fuentes S. Molluscum contagiosum in children and its relationship to attendance at swimming-pools: an epidemiological study. Dermatology. 1995;191:165.CrossRefPubMed
24.
Coloe J, Burkhart CN, Morrell DS. Molluscum contagiosum: what’s new and true? Pediatr Ann. 2009;38:321–5.CrossRefPubMed
25.
• Olsen JR, Piguet V, Gallacher J, Francis NA. Molluscum contagiosum and associations with atopic eczema in children: a retrospective longitudinal study in primary care. Br J Gen Pract. 2016;66:e53–8. This article reports epidemiologic data from a large retrospective longitudinal review of MC cases presenting to primary care as well as an age-sex matched case-cohort study of atopic dermatitis cases. A prior diagnosis of atopic dermatitis was found to be associated with slightly higher rates of MC (OR 1.13; 95% CI = 1.11 to 1.16;P < 0.005).CrossRefPubMed
26.
Silverberg NB. Molluscum contagiosum virus infection can trigger atopic dermatitis disease onset or flare. Cutis. 2018;102:191–4.PubMed
27.
Pauly CR, Artis WM, Jones HE. Atopic dermatitis, impaired cellular immunity, and molluscum contagiosum. Arch Dermatol. 1978;114:391–3.CrossRefPubMed
28.
Damevska K, Emurlai A. Molluscum contagiosum in a patient with atopic dermatitis. N Engl J Med. 2017;377:e30.CrossRefPubMed
29.
Agromayor M, Ortiz P, Lopez-Estebaranz JL, Gonzalez-Nicolas J, Esteban M, Martin-Gallardo A. Molecular epidemiology of molluscum contagiosum virus and analysis of the host-serum antibody response in Spanish HIV-negative patients. J Med Virol. 2002;66:151–8.CrossRefPubMed
30.
Watanabe T, Nakamura K, Wakugawa M, Kato A, Nagai Y, Shioda T, et al. Antibodies to molluscum contagiosum virus in the general population and susceptible patients. Arch Dermatol. 2000;136:1518–22.
31.
Simonart T, De Maertelaer V. Curettage treatment for molluscum contagiosum: a follow-up survey study. Br J Dermatol. 2008;159:1144–7.PubMed
32.
Basdag H, Rainer BM, Cohen BA. Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatr Dermatol. 2015;32:353–7.CrossRefPubMed
33.
Martin P. Interventions for molluscum contagiosum in people infected with human immunodeficiency virus: a systematic review. Int J Dermatol. 2016;55:956–66.CrossRefPubMed
34.
Kaufman WS, Ahn CS, Huang WW. Molluscum contagiosum in immunocompromised patients: AIDS presenting as molluscum contagiosum in a patient with psoriasis on biologic therapy. Cutis. 2018;101:136–40.PubMed
35.
Horn CK, Scott GR, Benton EC. Resolution of severe molluscum contagiosum on effective antiretroviral therapy. Br J Dermatol. 1998;138:715–7.CrossRefPubMed
36.
Hicks CB, Myers SA, Giner J. Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis. 1997;24:1023–5.CrossRefPubMed
37.
Calista D, Boschini A, Landi G. Resolution of disseminated molluscum contagiosum with highly active anti-retroviral therapy (HAART) in patients with AIDS. Eur J Dermatol. 1999;9:211–3.PubMed
38.
Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol. 2001;44:932–9.CrossRefPubMed
39.
Zaballos P, Ara M, Puig S, Malvehy J. Dermoscopy of molluscum contagiosum: a useful tool for clinical diagnosis in adulthood. J Eur Acad Dermatol Venereol. 2006;20:482–3.CrossRefPubMed
40.
Bauer JH, Miller OF, Peckham SJ. Medical pearl: confirming the diagnosis of molluscum contagiosum using 10% potassium hydroxide. J Am Acad Dermatol. 2007;56:S104–5.CrossRefPubMed
41.
Rajadhyaksha M, Marghoob A, Rossi A, Halpern AC, Nehal KS. Reflectance confocal microscopy of skin in vivo: from bench to bedside. Lasers Surg Med. 2017;49:7–19.CrossRefPubMed
42.
Lacarrubba F, Verzì AE, Ardigò M, Micali G. Handheld reflectance confocal microscopy for the diagnosis of molluscum contagiosum: histopathology and dermoscopy correlation. Australas J Dermatol. 2017;58:e123–5.CrossRefPubMed
43.
Ishikawa MK, Arps DP, Chow C, Hocker TL, Fullen DR. Histopathological features of molluscum contagiosum other than molluscum bodies. Histopathology. 2015;67:836–42.CrossRefPubMed
44.
Coloe J, Morrell DS. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum. Pediatr Dermatol. 2009;26:405–8.CrossRefPubMed
45.
• Jahnke MN, Hwang S, Griffith JL, Shwayder T. Cantharidin for treatment of facial molluscum contagiosum: a retrospective review. J Am Acad Dermatol. 2018;78:198–200. Although use of cantharidin on the face is often avoided due to concern for possible scarring, this retrospective review found no cases of permanent scarring in patients with facial MC treated with cantharidin, including patients with skin of color.CrossRefPubMed
46.
Ferrari B, Lösch AI, Larralde M. Comment on “Molluscum contagiosum: Review and update on management.”. Pediatr Dermatol. 2018;35:280–1.CrossRefPubMed
47.
• Forbat E, Al-Niaimi F, Ali FR. Molluscum contagiosum: review and update on management. Pediatr Dermatol. 2017;34:504–15. This review contains an excellent table summarizing the key clinical studies evaluating the treatment of MC including associated strength of recommendation taxonomy (SORT) criteria. No studies met grade A SORT criteria.CrossRefPubMed
48.
Peterson AR, Nash E, Anderson BJ. Infectious disease in contact sports. Sports Health. 2019;11:47–58.CrossRefPubMed
49.
Al-Mutairi N, Al-Doukhi A, Al-Farag S, Al-Haddad A. Comparative study on the efficacy, safety, and acceptability of imiquimod 5% cream versus cryotherapy for molluscum contagiosum in children. Pediatr Dermatol. 2010;27:388–94.CrossRefPubMed
50.
Handjani F, Behazin E, Sadati MS. Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial. J Dermatolog Treat. 2014;25:249–50.CrossRefPubMed
51.
Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23:574–9.
52.
Kelly V, Coulombe J, Lavoie I. Use of a disposable ear speculum: an alternative technique for molluscum contagiosum curettage. Pediatr Dermatol. 2018;35:418–9.CrossRefPubMed
53.
Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019;12:373–81.CrossRefPubMedPubMedCentral
54.
Moye V, Cathcart S, Burkhart CN, Morrell DS. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum. Dermatol Ther. 2013;26:445–51.CrossRefPubMed
55.
• Harel A, Kutz AM, Hadj-Rabia S, Mashiah J. To treat molluscum contagiosum or not-curettage: an effective, well-accepted treatment modality. Pediatr Dermatol. 2016;33:640–5. This retrospective study found that 70% of children treated with curettage (n= 1,878) cleared after a single treatment and only 4% required three or more treatments. Satisfaction rates were > 92%.CrossRefPubMed
56.
Binder B, Weger W, Komericki P, Kopera D. Treatment of molluscum contagiosum with a pulsed dye laser: pilot study with 19 children. J Dtsch Dermatol Ges. 2008;6:121–5.CrossRefPubMed
57.
Hancox JG, Jackson J, McCagh S. Treatment of molluscum contagiosum with the pulsed dye laser over a 28-month period. Cutis. 2003;71:414–6.PubMed
58.
Levine VJ, Geronemus RG. Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients. J Am Acad Dermatol. 1995;32:613–7.CrossRefPubMed
59.
Lebwohl MG, Heymann WR, Berth-Jones J, Coulson IH, editors. Treatment of skin disease: comprehensive and therapeutic strategies. 5th ed: Elsevier; 2018.
60.
Khare S, Dubey S, Nagar R. A new method for removal of eyelid margin molluscum. J Am Acad Dermatol. 2018;78:e151–2.CrossRefPubMed
61.
Weller R, O’Callaghan CJ, MacSween RM, White MI. Scarring in molluscum contagiosum: comparison of physical expression and phenol ablation. BMJ. 1999;319:1540.CrossRefPubMedPubMedCentral
62.
Moye VA, Cathcart S, Morrell DS. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum. Pediatr Dermatol. 2014;31:450–4.CrossRefPubMed
63.
• Vakharia PP, Chopra R, Silverberg NB, Silverberg JI. Efficacy and safety of topical cantharidin treatment for molluscum contagiosum and warts: a systematic review. Am J Clin Dermatol. 2018;19:791–803. This review of eight studies evaluating the use of cantharidin for the treatment of MC found reported efficacy to be highly variable (15.4–100%) but noted that the treatment was overall well-tolerated with high satisfaction ratings.CrossRefPubMed
64.
Coloe Dosal J, Stewart PW, Lin J-A, Williams CS, Morrell DS. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Pediatr Dermatol. 2014;31:440–9.CrossRefPubMed
65.
• Guzman AK, Schairer DO, Garelik JL, Cohen SR. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. Int J Dermatol. 2018;57:1001–6. This study found that cantharidin use was associated with higher rates of complete lesion clearance and reduction in MC lesion count compared to placebo. The authors advocate for shorter treatment intervals (every 3 weeks) and longer application time (6 hours).CrossRefPubMed
66.
Can B, Topaloğlu F, Kavala M, Turkoglu Z, Zindancı I, Sudogan S. Treatment of pediatric molluscum contagiosum with 10% potassium hydroxide solution. J Dermatolog Treat. 2014;25:246–8.CrossRefPubMed
67.
• Teixidó C, Díez O, Marsal JR, et al. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol. 2018;35:336–42. This small, double-blind, randomized, comparative trial found both 15% KOH and 10% KOH to be superior to placebo in treating MC, with 10% KOH being better tolerated by patients.CrossRefPubMed
68.
Chathra N, Sukumar D, Bhat RM, Kishore BN, Martis J, Kamath G, et al. A comparative study of 10% KOH solution and 5% imiquimod cream for the treatment of molluscum contagiosum in the pediatric age group. Indian Dermatol Online J. 2015;6:75–80.
69.
Short KA, Fuller LC, Higgins EM. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Pediatr Dermatol. 2006;23:279–81.CrossRefPubMed
70.
Saryazdi S. The comparative efficacy of benzoyl peroxide 10% cream and tretinoin 0.05% cream in the treatment of molluscum contagiosum. Pediatr Dermatol. 2004;21:399.
71.
Rajouria EA, Amatya A, Karn D. Comparative study of 5% potassium hydroxide solution versus 0.05% tretinoin cream for molluscum contagiosum in children. Kathmandu Univ Med J. 2011;9:291–4.CrossRef
72.
Bard S, Shiman MI, Bellman B, Connelly EA. Treatment of facial molluscum contagiosum with trichloroacetic acid. Pediatr Dermatol. 2009;26:425–6.CrossRefPubMed
73.
Dave D, Abdelmaksoud A. Glycolic acid cream for treatment of molluscum contagiosum. Dermatol Ther. 2018;31:e12630.CrossRefPubMed
74.
Niizeki K, Hashimoto K. Treatment of molluscum contagiosum with silver nitrate paste. Pediatr Dermatol. 1999;16:395–7.CrossRefPubMed
75.
Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatolog Treat. 2005;16:336–40.CrossRefPubMed
76.
Padilla España L, Mota-Burgos A, Martinez-Amo JL, Benavente-Ortiz F, Rodríguez-Bujaldón A, Hernández-Montoya C. Recalcitrant molluscum contagiosum successfully treated with sinecatechins. Dermatol Ther. 2016;29:217–8.CrossRefPubMed
77.
Capriotti K, Stewart K, Pelletier J, Capriotti J. Molluscum contagiosum treated with dilute povidone-iodine: a series of cases. J Clin Aesthet Dermatol. 2017;10:41–5.PubMedPubMedCentral
78.
79.
• Katz KA, Williams HC, van der Wouden JC. Imiquimod cream for molluscum contagiosum: neither safe nor effective. Pediatr Dermatol. 2018;35:282–3. Short letter summarizing the evidence against the use of imiquimod for the treatment of MC.CrossRefPubMed
80.
Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol. 1996;13:310–2.CrossRefPubMed
81.
Antony F, Cliff S, Ahmad A, Holden C. Double-blind placebo-controlled study of oral cimetidine treatment for molluscum contagiosum. British J Dermatol-Suppl. 2001;145:126.
82.
Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. 2008;25:189–92.CrossRefPubMed
83.
Enns LL, Evans MS. Intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosum in children. Pediatr Dermatol. 2011;28:254–8.CrossRefPubMed
84.
Calista D. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. J Eur Acad Dermatol Venereol. 2000;14:484–8.CrossRefPubMed
85.
Briand S, Milpied B, Navas D, Thomare P, Stalder JF. 1% topical cidofovir used as last alternative to treat viral infections. J Eur Acad Dermatol Venereol. 2008;22:249–50.PubMed
86.
Erickson C, Driscoll M, Gaspari A. Efficacy of intravenous cidofovir in the treatment of giant molluscum contagiosum in a patient with human immunodeficiency virus. Arch Dermatol. 2011;147:652–4.CrossRefPubMed
87.
Meadows KP, Tyring SK, Pavia AT, Rallis TM. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol. 1997;133:987–90.CrossRefPubMed
88.
Haque M, Coury DL. Treatment of molluscum contagiosum with an East Indian sandalwood oil product. J Dermatolog Treat. 2018;29:531–3.CrossRefPubMed
89.
Kwon HS, Lee JH, Kim GM, Choi EH, Bae JM. Topical evening primrose oil as a possible therapeutic alternative in children with molluscum contagiosum. Clin Exp Dermatol. 2017;42:923–5.CrossRefPubMed
90.
Markum E, Baillie J. Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of molluscum contagiosum in children. J Drugs Dermatol. 2012;11:349–54.PubMed
91.
Burke BE, Baillie J-E, Olson RD. Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in children. Biomed Pharmacother. 2004;58:245–7.CrossRefPubMed
92.
Burkhard PR, Burkhardt K, Haenggeli CA, Landis T. Plant-induced seizures: reappearance of an old problem. J Neurol. 1999;246:667–70.CrossRefPubMed
93.
Viswanath V, Shah RJ, Gada JL. Intralesional 5-fluorouracil: novel therapy for extensive molluscum contagiosum in an immunocompetent adult. Indian J Dermatol Venereol Leprol. 2017;83:265–6.CrossRefPubMed
94.
Kachhawa D, Sonare D, Vats G. Autoinoculation as a treatment modality for molluscum contagiosum: a preliminary uncontrolled trial. Indian J Dermatol Venereol Leprol. 2018;84:76–8.CrossRefPubMed
95.
Maiolo C, Marshman G. Zoster immunoglobulin-VF: a potential treatment for molluscum contagiosum in immunosuppressed children. Pediatr Dermatol. 2015;32:e193.CrossRefPubMed
96.
Shin K, Bae K-N, Kim H-S, Kim B-S, Kim M-B, Ko H-C. Ingenol mebutate gel for the treatment of molluscum contagiosum: an open-label comaparative pilot study. J Am Acad Dermatol. 2019.
97.
Schianchi R, Nazzaro G, Veraldi S. Treatment of molluscum contagiosum with hydrogen peroxide. Clin Exp Dermatol. 2018;43:66–7.CrossRefPubMed
98.
Böhm M, Luger TA, Bonsmann G. Disseminated giant molluscum contagiosum in a patient with idiopathic CD4+ lymphocytopenia. Successful eradication with systemic interferon. Dermatology. 2008;217:196–8.CrossRefPubMed
99.
Kilic SS, Kilicbay F. Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome. Pediatrics. 2006;117:e1253–5.CrossRefPubMed
100.
Melchers RC, Willemze R, Jansen PM, Vermaat JSP, Vermeer MH, Quint KD. Generalized molluscum contagiosum successfully treated with interferon-alpha in a patient with folliculotropic mycosis fungoides. Case Rep Dermatol. 2019;11:52–6.CrossRefPubMedPubMedCentral
101.
Gao Y-L, Gao X-H, Qi R-Q, Xu JL, Huo W, Tang J, et al. Clinical evaluation of local hyperthermia at 44 °C for molluscum contagiosum: pilot study with 21 patients. Br J Dermatol. 2017;176:809–12.
Metadata
Title
Molluscum Contagiosum: Review and Update on Clinical Presentation, Diagnosis, Risk, Prevention, and Treatment
Authors
Gabrielle Robinson
Steven Townsend
Marla N. Jahnke
Publication date
01-03-2020
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 1/2020
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-020-00289-z

Other articles of this Issue 1/2020

Current Dermatology Reports 1/2020 Go to the issue

Photodermatology (B Adler and V DeLeo, Section Editor)

Phototherapy: a Review and Update of Treatment Options in Dermatology

Photodermatology (B Adler and V DeLeo, Section Editor)

Sunscreen Safety: a Review of Recent Studies on Humans and the Environment

Veterinary Dermatology (A Rostaher and N Fischer, Section Editors)

What Can We Learn from Canine Atopic Dermatitis History?

Wound Care (H Lev-Tov, Section Editor)

Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Infectious Disease and Dermatology (C Beard and K. Krishnamurthy, SECTION EDITORS)

Risk, Prevention, Diagnosis, and Management of Cellulitis and Erysipelas

Photodermatology (B Adler and V DeLeo, Section Editor)

Photoaging: a Review of Current Literature